Christopher A. Viehbacher

2023-10-30T11:41:22-05:00October 26, 2023|

Mr. Christopher Viehbacher is president and CEO of Biogen, a multinational biotechology company. He is also a founding partner of Gurnet Point Capital, a Boston-based investment fund associated with the Bertarelli family with a $2 billion capital allocation. He is [...]

William C. Louv, PhD

2023-10-30T13:03:10-05:00October 26, 2023|

Dr. Bill Louv was named Chief Executive Officer of the CEO Roundtable on Cancer and Project Data Sphere in March 2022 after serving as Interim CEO since January 1, 2022. He joined Project Data Sphere in March 2018 as President. Previously, he held key [...]

Belén Garijo, MD

2023-10-30T11:40:01-05:00October 26, 2023|

Belén Garijo is Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015. In July 2020, Belén [...]

Peter WT Pisters, MD, MHCM

2023-10-30T11:36:10-05:00October 26, 2023|

Peter WT Pisters, M.D., took the helm as president of The University of Texas MD Anderson Cancer Center in 2017, and forged a new path forward to end cancer by transforming the culture of the nation’s top-ranked cancer center. With [...]

Scott White

2023-10-30T11:42:52-05:00October 26, 2023|

Scott White is Company Group Chairman, North America, at the Janssen Pharmaceutical Companies of Johnson & Johnson. A member of the Pharmaceuticals Group Operating Committee, he is responsible for leading Janssen’s efforts to transform the health of people in the [...]

John Crumpler

2023-10-30T11:26:39-05:00October 26, 2023|

John co-founded Hatteras in 2000 after a successful career as a technology entrepreneur. After a decade in politics and public policy, he was founder and CEO of E-Comm, Inc., a software development and services firm specializing in remote and mobile [...]

James Goodnight, PhD

2023-10-30T11:40:42-05:00October 26, 2023|

As the CEO of SAS, the world’s leading business analytics software vendor, Jim Goodnight has led the company since its inception in 1976, overseeing an unbroken chain of revenue growth and profitability unprecedented in the industry. He is recognized globally [...]

Major General Elder Granger, MD

2023-10-30T13:02:16-05:00October 26, 2023|

Since 2009, Major General Granger has been the President and CEO of THE 5Ps, LLC, a health care, education, and leadership consulting organization in Colorado. Prior to his retirement from the US Army in 2009, Dr. Granger served as the Deputy Director and [...]

David M. Reese, MD

2023-10-30T11:40:28-05:00October 26, 2023|

Dr. David M. Reese is executive vice president, Research and Development. In this role, Dr. Reese oversees Discovery Research, Global Development, Global Regulatory Affairs and Safety, as well as Global Medical. Dr. Reese joined Amgen in 2005 and has served [...]

Norman “Ned” Sharpless, MD

2023-10-30T11:41:09-05:00October 26, 2023|

Dr. Sharpless led the National Cancer Institute (NCI) from 2017 to 2022. He was appointed acting commissioner of the U.S. Food and Drug Administration (FDA) in 2019 and served for seven months before returning to his position at the NCI. [...]

Go to Top